National Heart & Lung Institute (NHLI)
27 Jun 2012
Joseph Footitt, Walport Clinical Lecturer, NHLI, dies tragically.
04 Jul 2013
The increased risk of heart attack or stroke associated with many arthritis drugs may be avoidable.
02 May 2013
What is known about the new strain of influenza emerging in China, and how concerned should we be?
Researchers at Imperial College London have begun the first UK clinical trials of a gene therapy for heart failure.
Last month the House of Commons hosted a group of early career researchers, including 16 from Imperial, who presented their science to politicians.
Imperial College London has been granted Athena Swan silver status, one of only three universities to ever be recognised in this way.
Imperial will lead one of three new British Heart Foundation (BHF) research centres focussed on repairing the damage caused by a heart attack.
Peter Kohl heads up the Cardiac Biophysics and Systems Biology group at Imperial which tackles heart science issues at various scales.
Scientists have shed light on a common bleeding disorder by growing and analysing patients' stem cells to discover the cause of their disease.
Professor Amanda Fisher, Head of the Institute of Clinical Sciences, hosted this prestigious event celebrating women in science.
Scans can help doctors decide which patients should be fitted with an implanted defibrillator.
Contrary to medical opinion, blood-thinning medications may be safe and beneficial for some patients with an inherited bleeding disorder.
£1.8 million award will fund research into inherited cardiac conditions
More NHLI Reporter news
Main campus address:
Imperial College London, South Kensington Campus, London SW7 2AZ tel: +44 (0)20 7589 5111Campus maps and information
| About this site
© Copyright 2013 Imperial College London